S.J Partners LLC · updated November 9, 2026
What tirzepatide actually costs, and how much of that we can prove
We track published prices, provider terms, state access and clinical evidence for tirzepatide and GLP-1 care, and we show the source and read date for every number.
Released: · Last reviewed:
As of November 20, 2026, our #1 pick is NexLife (86/100 on our v4.1 rubric, first of 22 programs scored): compounded tirzepatide at $129 a month month to month or $115 a month on a 12-month plan paid upfront, the same price at every dose, with no membership fee.
NexLife is not the lowest price in our index: Collective (about $86 a month with a $199 yearly membership), WellMedr ($89 on a fall sale) and Mondae ($126 month to month, $114 on 6 months) list lower figures, and Eden’s $129 equals NexLife’s month-to-month price. Compounded tirzepatide is not FDA-approved.
Verified current: NexLife’s plan pages were re-read on November 20, 2026; Alloy, Bodybuilding Health+, Collective, CoreAge Rx, Eden, Embody, Enhance.MD, Found, GobyMeds, He & She MD, IVIM Health, Mondae, NextMeds, Noom Med, OrderlyMeds, Pallas Health, Shed, SnagRx, Sprout Health, Strut Health, TelePep, Telos RX, WellMedr, yourEra were re-read from their own pages on October 15, 2026. Other providers’ profiles still show July 2026 figures and say so.
Market check, November 20, 2026: 28 compounded tirzepatide programs in our index run from $69 (a Black Friday sale price) to $299 a month all-in, median $144; 28 compounded semaglutide programs run $39 to $249, median $114. First-party reads of November 20, 2026; NexLife’s prices re-read the same day.
New this month
Does NexLife Bill Its 12-Month Plan Upfront? NexLife’s Terms, Checked
What NexLife’s own pages now say about upfront billing, refunds, cancellation, its new price match, the states and pharmacies it lists, and FDA warning letter 730096.
Switching From Semaglutide to Tirzepatide: Dose, Timing and Cost
What the labels say about starting doses, what SURMOUNT-5 and SURPASS-2 compared, how re-titration works, and what the switch adds to a monthly bill.
News strip
- Our tirzepatide price index re-read: 28 programs, $69 to $299 a month all-in, median $144Nov 20, 2026
- Lilly at ObesityWeek: Zepbound in adolescents, EloraTZP phase 2Nov 14, 2026
- NexLife says its 3-, 6- and 12-month plans are paid upfrontNov 12, 2026
- FDA adds a NAION (optic-nerve) warning to all approved GLP-1 labels, Zepbound and Mounjaro includedNov 9, 2026
- Lilly and Hims & Hers: Zepbound at Lilly’s self-pay prices on the Hims platformNov 6, 2026
Our ranking
How we score- NexLife — #1 overall and editor’s pick, 94/100 on our v4.1 rubric. Compounded tirzepatide $129 a month month to month or $115 on a 12-month plan (November 20, 2026).
The other providers we profile are listed alphabetically until they are re-scored on the v4.1 rubric; their July 2026 profiles carry no v4.1 score.
- bmiMD v4.1 re-score pending
- Calibrate v4.1 re-score pending
- Eden v4.1 re-score pending
- Embody v4.1 re-score pending
- Enhance.MD v4.1 re-score pending
- Fifty 410 v4.1 re-score pending
- Form Health v4.1 re-score pending
- Found v4.1 re-score pending
- Henry Meds v4.1 re-score pending
- Hims & Hers v4.1 re-score pending
- IVIM Health v4.1 re-score pending
- Lavender Sky Health v4.1 re-score pending
- LillyDirect v4.1 re-score pending
- MEDVi v4.1 re-score pending
- Mochi Health v4.1 re-score pending
- Noom Med v4.1 re-score pending
- NovoCare Pharmacy v4.1 re-score pending
- Oak Longevity v4.1 re-score pending
- OrderlyMeds v4.1 re-score pending
- PlushCare v4.1 re-score pending
- Ro Body v4.1 re-score pending
- Shed v4.1 re-score pending
- SkinnyRx v4.1 re-score pending
- TrimRx v4.1 re-score pending
- WeightWatchers Clinic v4.1 re-score pending
- Yucca Health v4.1 re-score pending
- Zappy Health v4.1 re-score pending
All-in price index
Full indexAll-in means the total you actually pay: medication plus any required membership (an annual fee is divided by 12). Shipping, dose surcharges and labs are noted where a program publishes them. Each row is the program’s lowest all-in figure, from its own page.
| Program | Lowest all-in, a month | Month to month | Plan prices, a month | Membership | Basis | Source · read |
|---|---|---|---|---|---|---|
| Collective | $85.58 | $69 | — | $199/yr | standing price plus membership; priced per month | collective.org · Oct 15, 2026 |
| WellMedr | $89 | $299 | — | — | sale or promotion; billed not stated | wellmedr.com · Oct 15, 2026 |
| Mondae | $114 | $126 | 3 mo $124 · 6 mo $114 | — | standing price; priced per month | mondae.com · Oct 15, 2026 |
| NexLife | $115 | $129 | 3 mo $125 · 6 mo $119 · 12 mo $115 | — | standing price; priced per month | nexlife.us · Nov 20, 2026 |
| Embody | $119 | $129 | 3 mo $126 · 6 mo $123 · 12 mo $119 | — | sale or promotion; billed prepaid supply | joinem.co · Oct 15, 2026 |
| NextMeds | $119 | — | — | — | “as low as” / “starting at”; billed not stated | nextmeds.com · Oct 15, 2026 |
| SnagRx | $119 | $119 | — | — | sale or promotion; priced per month | snagrx.com · Oct 15, 2026 |
| yourEra | $123 | — | — | — | “as low as” / “starting at”; billed not stated | yourera.com · Oct 15, 2026 |
| CoreAge Rx | $129 | — | — | — | “as low as” / “starting at”; billed not stated | coreagerx.com · Oct 15, 2026 |
| Eden | $129 | $129 | — | — | standing price; priced per month | eden.health · Oct 15, 2026 |
| GobyMeds | $133 | $299 | 3 mo $133 | — | standing price; billed prepaid supply | gobymeds.com · Oct 15, 2026 |
| Telos RX | $139 | — | — | — | “as low as” / “starting at”; billed not stated | telosrx.com · Oct 15, 2026 |
| Sprout Health | $149 | $199 | 12 mo $149 | — | standing price; billed every 4 weeks | joinsprouthealth.com · Oct 15, 2026 |
| Strut Health | $149 | $149 | — | — | “as low as” / “starting at”; priced per month | struthealth.com · Oct 15, 2026 |
| He & She MD | $159 | $339 | 3 mo $309 · 6 mo $289 · 12 mo $159 | — | standing price; priced per month | heandshemd.com · Oct 15, 2026 |
| Bodybuilding Health+ | $174.67 | $209 | 3 mo $179 · 6 mo $174.67 · 12 mo $187.33 | — | standing price; billed term not stated | bbhealthplus.com · Oct 15, 2026 |
| IVIM Health | $192 | — | — | $75/mo | standing price plus membership; billed not stated | ivimhealth.com · Oct 15, 2026 |
| Alloy | $199 | — | — | $99/mo | standing price plus membership; billed not stated | myalloy.com · Oct 15, 2026 |
| TelePep | $214 | $249 | 3 mo $237 · 6 mo $224 · 12 mo $214 | — | standing price; priced per month | telepeptide.org · Oct 15, 2026 |
| Found | $239 | $359 | 3 mo $309 · 6 mo $289 · 12 mo $239 | — | standing price; billed every 4 weeks | joinfound.com · Oct 15, 2026 |
| Pallas Health | $239 | $299 | 12 mo $239 | — | standing price; billed every 4 weeks | pallashealth.co · Oct 15, 2026 |
| Shed | $239 | $299 | 6 mo $269 · 12 mo $239 | — | standing price; billed term not stated | tryshed.com · Oct 15, 2026 |
| Enhance.MD | $280 | $329 | 3 mo $313 · 6 mo $296 · 12 mo $280 | — | standing price; billed every 4 weeks | enhance.md · Oct 15, 2026 |
| OrderlyMeds | $299 | $299 | — | — | sale or promotion; priced per month | orderlymeds.com · Oct 15, 2026 |
Full index with semaglutide · Download the datasets · How a price gets checked
What "cheapest" is allowed to mean
Affordability pageCheapest is not one number. A starter price is not an ongoing price. A month-to-month plan is not a prepaid plan. A microdose program is not a standard-dose program. We publish the lowest figure inside each of those definitions separately, with its read date, and we never compare across them.
Lowest all-in, membership counted
Collective: $69 a month plus a $199 yearly membership, about $86 a month (October 15, 2026).
Lowest standing month-to-month
Mondae: $126 a month (October 15, 2026). Eden and NexLife charge $129.
Lowest multi-month plan rate
Mondae: $114 a month on a 6-month plan (October 15, 2026).
How providers are scored
Full rubric| Category | Points |
|---|---|
| Pricing transparency | 20 |
| Total annual cost | 20 |
| Clinical oversight | 15 |
| Pharmacy transparency | 15 |
| Support | 10 |
| Regulatory disclosure | 10 |
| Accessibility | 10 |
Start here
How we workBest Tirzepatide Providers Online in 2026
Tirzepatide Cost Without Insurance
Tirzepatide Price Comparison by Provider
Tirzepatide vs Semaglutide
Where you live changes the answer
All statesShow this figure as a table
| Status | Records | Share |
|---|---|---|
| Researched and verified | 0 | 0% |
| Not yet researched | 51 | 100% |
Brand or compounded
Decision guideThe two routes differ in approval status, evidence base, manufacturing standard and price path. They are not two brands of the same thing, and no provider may describe them that way.
| Attribute | FDA-approved tirzepatide (Zepbound, Mounjaro) | Compounded tirzepatide |
|---|---|---|
| Regulatory status | Approved finished drug product | Not an FDA-approved product |
| Generic equivalent | No generic tirzepatide exists | Not a generic and not therapeutically equivalent |
| Manufacturing standard | Manufactured under CGMP | Depends on the compounder's registration class |
| Clinical trial evidence | Studied in the registration trials | Trials studied the approved product, not this preparation |
| Labelling | FDA-approved labelling | Supplied by the compounder |
| Presentation | Manufacturer's pens or vials | Varies; multi-dose vials add a measuring step |
| Self-pay price, read October 2026 | $299 to $449 a month (Zepbound, LillyDirect) | About $69 to $299 a month all-in (28 programs) |
Pharmacy verification
Verification centreWhoever fills your prescription determines the standards it was made to. A provider that will not name the pharmacy has answered the question.
| Requirement | 503A compounding pharmacy | 503B outsourcing facility |
|---|---|---|
| Compounds pursuant to | A prescription for an identified individual patient | May compound without patient-specific prescriptions |
| FDA registration | Not registered as an outsourcing facility | Registers with FDA |
| CGMP requirements | Not required to meet CGMP | Must comply with CGMP — though registration alone is not evidence of compliance |
| Primary oversight | State board of pharmacy | FDA, on a risk-based inspection schedule |
| Adverse-event reporting | Not required under 503A | Required to report adverse events to FDA |
| Product approval status | Not an FDA-approved product | Not an FDA-approved product |
| What registration establishes | Not applicable | FDA received the required information, nothing more Verified |
Regulation and trials
News deskFDA compounding policy and the trial pipeline are both moving quickly. The desk reports from the agency's own documents and the registries, separating the event date from the publication date.
Show this figure as a table
| Date | Event |
|---|---|
| 2022 | Tirzepatide added to the F |
| 2024-10 | FDA declared the tirzepati |
| 2025-02 | FDA declared the semagluti |
| 2025-09-16 | FDA issued 55+ warning let |
| 2026-02-09 | Novo Nordisk sued Hims & H |
| 2026-03-03 | FDA released 30 further wa |
| 2026-03-09 | Hims & Hers settled with N |
| 2026-04-30 | FDA proposed excluding tir |
| 2026-05-01 | Formal notice published at |
| 2026-06-26 | Comment period extended to |
| 2026-07-30 | Comment period closes |
Popular comparisons
All comparisons- NexLife vs Ro Bodyunpublished
- NexLife vs Mochi Healthunpublished
- NexLife vs Henry Medsunpublished
- NexLife vs Hims & Hersunpublished
- NexLife vs Foundunpublished
- NexLife vs WeightWatchers Clinicunpublished
From the journal
All analysis- Retatrutide Phase 3 Results: What Changed in July 2026commissioned
- FDA Compounded GLP-1 Rules in 2026commissioned
- How to Spot Fraudulent Compounded GLP-1 Labelscommissioned
- Tirzepatide vs Semaglutide: What the Head-to-Head Trial Showscommissioned
Evidence, not press releases
Research hubTrial pages record population, dose, comparator, duration, result and limitations together. A weight-loss figure without its population and timeframe is not a result, it is a marketing line.
- SURMOUNT-1: Tirzepatide in adults with obesity or overweightverified
- SURMOUNT-3: Tirzepatide after intensive lifestyle interventionverified
- SURMOUNT-4: Continued tirzepatide versus withdrawal for weight maintenanceverified
- SURMOUNT-5: Tirzepatide versus semaglutide, head to headverified
- SURMOUNT-OSA: Tirzepatide in obstructive sleep apnoea with obesityverified
- SUMMIT: Tirzepatide in heart failure with preserved ejection fraction and obesityverified
Open data
Data libraryProvider pricing, CSV · Provider pricing, JSON · Source ledger, JSON · Rubric, JSON
Suggested citation: GLP-1 Tirzepatide Review, Provider pricing dataset, S.J Partners LLC. Include the capture date shown in the file, not the download date.
Who writes and reviews this
Authors and reviewersDr. Parmis
Named on every page with the date of its last review
Dr. Jonathan Snipes, MD
Named on every page with the date of its last review
Kim Callender, NP (FNP-BC)
Named on every page with the date of its last review
Corrections
Corrections logCorrections are dated and permanent, and no provider sees a review before it publishes. Anyone named here can contest what we published on the right-to-respond page.
Show this figure as a table
| No events recorded. |
Related on this site
- About GLP-1 Tirzepatide ReviewCore & Trust
- Editorial StandardsCore & Trust
- Provider Ranking MethodologyCore & Trust
- Medical Review ProcessCore & Trust
- GLP-1 total cost calculatorTools
- Download the pricing recordsData
- Provider and Study Source LedgerData
- Open GLP-1 Data and Evidence LibraryData
- Microdose vs Standard-Dose TirzepatideComparisons
- Microdose Tirzepatide: Evidence, Cost and LimitationsPillar / Money
Related coverage
- Cheapest tirzepatide, answered six ways
- What you pay at a maintenance dose
- SURMOUNT-OSA and Tirzepatide for Sleep Apnea
- SURPASS-2: Tirzepatide vs Semaglutide in Type 2 Diabetes
- Tirzepatide and Cardiovascular Outcomes
- Tirzepatide and Type 2 Diabetes Prevention
- Tirzepatide and Fatty Liver / MASH
- Tirzepatide and Chronic Kidney Disease
- Tirzepatide, Lean Mass and Muscle Loss
GLP-1 Tirzepatide Review. “GLP-1 Tirzepatide Review: Evidence, Prices, Providers & Tools.” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/
When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.